Jinghua Shi, Gaonian Zhao, Su Jiang
Department of Rehabilitation Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Jiangsu, China.
Postepy Dermatol Alergol. 2024 Dec 2;42(2):150-155. doi: 10.5114/ada.2024.145458. eCollection 2025 Apr.
Adult asthma as inflammatory-based disease can be an independent risk factor for stroke.
To evaluate the relationship between adult asthma and cerebrovascular accident.
120 patients (asthma stroke, asthma non-stroke, and non-asthma stroke groups) who were matched for age and gender were included in this prospective cohort study to observe pulmonary function changes and recurrence rate of stroke among asthmatic patients during 6-month follow-up after first even after first even stroke.
In the asthma stroke group, post stroke forced vital capacity (FVC) (3.04 ±0.13 vs. 2.58 ±0.15, 0.006), forced expiratory volume in 1 s (FEV1) (2.68 ±0.15 vs. 2.01 ±0.12, 0.02), FEV1/FVC (0.88 ±0.03 vs. 0.77 ±0.02, 0.001), maximal inspiratory pressure (MIP) (74.05 ±5.36 vs. 56.57 ±3.83, 0.001), maximal expiratory pressure (MEP) (88.30 ±3.65 vs. 71.42 ±3.98, 0.001) and 6-minute walk test (6MWT) (446.32 ±47.56 vs. 338.62 ±28.85, 0.001) were significantly decreased in comparison to before stroke. Also, stroke recurrence was 32.5% in the asthma stroke group and 12.5% in the non-asthma stroke group, which was significantly higher in the asthma stroke group ( 0.001). Comparison of pulmonary function showed that all FVC (2.58 ±0.15 vs. 3.36 ±0.14, 0.001), FEV1 (2.01 ±0.12 vs. 2.73 ±0.16, 0.001), FEV1/FVC (0.77 ±0.02 vs. 0.81 ±0.03, 0.001), MIP (56.57 ±3.83 vs. 70.62 ±2.77, 0.001), MEP (71.42 ±3.98 vs. 85.97 ±2.31, 0.001) and 6MWT (338.62 ±28.85 vs. 385.67 ±29.82, 0.001) in the asthma stroke group were significantly decreased in comparison to the non-asthma stroke group.
FVC, FEV1, FEV1/FVC, MIP, MEP and 6MWT were significantly decreased in allergic asthma patients after stroke, also adult asthma can increase the risk of recurrence of risk of stroke in asthmatic stroke patients.
成人哮喘作为一种基于炎症的疾病,可能是中风的独立危险因素。
评估成人哮喘与脑血管意外之间的关系。
本前瞻性队列研究纳入了120例年龄和性别匹配的患者(哮喘中风组、哮喘非中风组和非哮喘中风组),以观察哮喘患者首次中风后6个月随访期间的肺功能变化和中风复发率。
与中风前相比,哮喘中风组中风后的用力肺活量(FVC)(3.04±0.13对2.58±0.15,P=0.006)、第1秒用力呼气容积(FEV1)(2.68±0.15对2.01±0.12,P=0.02)、FEV1/FVC(0.88±0.03对0.77±0.02,P=0.001)、最大吸气压力(MIP)(74.05±5.36对56.57±3.83,P=0.001)、最大呼气压力(MEP)(88.30±3.65对71.42±3.98,P=0.001)和6分钟步行试验(6MWT)(446.32±47.56对338.62±28.85,P=0.001)均显著降低。此外,哮喘中风组的中风复发率为32.5%,非哮喘中风组为12.5%,哮喘中风组显著更高(P=0.001)。肺功能比较显示,哮喘中风组的所有FVC(2.58±0.15对3.36±0.14,P=0.001)、FEV1(2.01±0.12对2.73±0.16,P=0.001)、FEV1/FVC(0.77±0.02对0.81±0.03,P=0.001)、MIP(56.57±3.83对70.62±2.77,P=0.001)、MEP(71.42±3.98对85.97±2.31,P=0.001)和6MWT(338.62±28.85对385.67±29.82,P=0.001)与非哮喘中风组相比均显著降低。
中风后过敏性哮喘患者的FVC、FEV1、FEV1/FVC,、MIP、MEP和6MWT均显著降低,成人哮喘还会增加哮喘中风患者中风复发的风险。